Financials
- Fiscal year
- 2024
- Turnover
- €5.2m
- Loss
- -€471,288
- Solvency
- 78.6%
Turnover▼ 12.6%
Net result
20232024
CORIS BIOCONCEPT
ActiveSummary
CORIS BIOCONCEPT has been active since 1996 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €5.4m and a net result of -€471,288. Equity remains stable across the filed fiscal years (±0.4% per year). Its solvency ranks better than 74% of 1247 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).
Overview
Activity
Nutrition and dietetics services
NACE 86995Wholesale of pharmaceutical and medical goods NACE 46460NACE 51460
#3 company by total assets in Gembloux, Health and social work sector2 sites
Size
€5.2mturnover 2024
- Staff
- 31.5 FTE
- Equity
- €5.4m
- Loss
- -€471,288
Structure
- Parent
- Coris Holdings · 100%
Accounts 63 d overdue0 of 12 deeds read
Why 89- Loss of €471,288, the second in a row (FY 2024)+ Sector Human health activities (NACE 86)+ Liquidity: current ratio 5.39, cash €1.6m+ Founded in 1996Show the evidence
Checked score
Score 2024
89
/ 100
Excellent
Probability in this band: under 0.55%
Better than 41% of its sector peers (NACE 86, small)
Performance against the sector, not lower risk
Financial strength · tick = 2023
Strong
Solvency
100=
equity 78.6% of total assets
Liquidity
76-18
short-term debt 14.7% · cash 23.4%
Profitability
47+39
return on assets -6.8%
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 6 months
05-2026: 0.1%lowest value
06-2026: 0.1%▲ +1.1% vs 05-2026
07-2026: 0.1%▲ +6.6% vs 06-2026
08-2026: 0.1%▲ +32.0% vs 07-2026
09-2026: 0.1%▼ -0.8% vs 08-2026
10-2026: 0.2%▲ +26.0% vs 09-2026highest value
- Sector Human health activities (NACE 86) lowers the probability
- Loss of €471,288, the second in a row (FY 2024) raises the probability
- Liquidity: current ratio 5.39, cash €1.6m lowers the probability
- Founded in 1996 lowers the probability for this profile
Credit up to €480,000 at 30 days acceptable
Liquidity ample (current ratio 5.39 against 7.14 in 2023; short-term debt: 14.7% and cash: 23.4% of total assets), and 21.4% of the assets are financed with debt.
How it is calculated
The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 86, small). Better than this share of them on solvency 77%, liquidity 69%, profitability 9%, growth against the median 9%. That is performance, not lower risk; the band itself always comes from the probability.
Bankruptcy probability: model pd-v3.202610021621, computed on 02-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.
Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Persistent losses
Two consecutive loss-making years (2023 and 2024); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2024Net result per financial year
18192021222324
2018 to 2024 · latest year -€471,288
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 25-09-2025, 56 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 9 filingsDeviation from the deadline
2025
not confirmed
2024
56 d late
2023
20 d late
2022
29 d late
2021
30 d late
2020
79 d late
2019
115 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 55 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (1)
- Annual accounts filedfiscal year 2024 · full…
- Annual accounts filedfiscal year 2023 · abbreviated…
- Annual accounts filedfiscal year 2023 · full…
Key points
- Risk: 4 loss-making years in a rowloss fiscal year 2024 -€471,288 View
- Caution: Among the weakest 5% on net resultsector median €72,508 · 1,243 companies -€471,288 View
- Caution: Accounts not fileddeadline was 31-07-2026 63 d late View
- Controlled by Coris Holdings 100% View
- Positive: Result rose in 2024from -€852,803 to -€471,288 ▲ 44.7% View
- EU research moneyEU contribution €3.4m View
By topic
Board & ownership
- Parent
- Coris Holdings · 100%
Timeline
- Events
- 14
- Since
- 2017
- 25-09-2025Annual accounts filed
- 27-05-2025Annual accounts filed
- 20-08-2024Annual accounts filed
Company details
- Sites
- 2
- Legal form
- Private limited company
- Activity
- Nutrition and dietetics servicesNACE 86995
- Founded
- 16-10-1996
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Is the workforce growing, and do people stay?Employer check Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Subsidies
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.